Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 14, 2005; 11(38): 6038-6042
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6038
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6038
UC patients (95%CI) | Healthy controls (95%CI) | |
Subjects (n) | 40 | 50 |
Gender (female/male) | 20/20 | 25/25 |
Mean age (yrSD)(range) | 41.65±15.21 | 39.96±14.33 |
[36.78-46.52] (17-71) | [35.89-44.03] (17-72) | |
Mean disease duration (mo±SD)(range) | 56.65±63.18 | |
[36.44-76.86] (3-216) | ||
Current smoking (%) | 9 (22.5) | |
Extent of UC (%) | ||
Rectum/sigmoid | 9 (22.5) | |
Left colitis | 22 (55.5) | |
Pancolitis | 9 (22.5) | |
Activity of UC (%) | ||
Active | 28 (70) | |
Inactive | 12 (30) | |
Extraintestinal complications (%) | 6 (15) | |
Thrombotic complications (%) | 2 (5) | |
Medical treatment | ||
None | 1 (2.5) | |
5-ASA | 35 (87.5) | |
SASP | 1 (2.5) | |
Steroids | 17 (42.5) | |
Immunosuppressors (AZA/6-MP) | 11 (27.5) |
- Citation: Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N. Hyperhomocysteinemia in ulcerative colitis is related to folate levels. World J Gastroenterol 2005; 11(38): 6038-6042
- URL: https://www.wjgnet.com/1007-9327/full/v11/i38/6038.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i38.6038